A new peptide-based vaccine elicited antigen-specific T cell responses in high-risk patients, demonstrating proof of concept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results